Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease.
Schlitt A, Blankenberg S, Yan D, von Gizycki H, Buerke M, Werdan K, Bickel C, Lackner KJ, Meyer J, Rupprecht HJ, et al. Nutr Metab (Lond). 2006 Jan 5; 3:5. Epub 2006 Jan 5.